THE CONFERENCE STARTS IN:

DAYS

HOURS

MIN

SEC

DATE

APRIL 29, 2025:
- SLOT 1: 12:00 PM (CEST)
- SLOT 2: 5:00 PM (CEST)
(2 sessions with the same content)

CHAIRPERSONS

Reinhold Kreutz Germany

Liffert Vogt The Netherlands

PATRONAGE

Visit website

PARTNER

Visit website

PROGRAM

29

April

Tuesday

ESH MASTERPLAN for hypertension management in CKD

SLOT 1
(2 sessions with the same content)

CHAIRPERSONS

Reinhold Kreutz (Germany)
Liffert Vogt (The Netherlands)

12:00pm - 12:01pm

INTRODUCTION

Reinhold Kreutz (Germany)

12:01pm - 12:14pm

MEASURE BP –DIAGNOSE AND ASSESS PATIENT
BP measurements including ABPM, and the role of measuring uACR

Lene Halvorsen (Norway)

12:14pm - 12:27pm

SELECT THERAPY
BP treatment in patients with CKD including SGLT2i and nsMRA.

Pantelis Sarafidis (Greece)

12:27pm - 12:40pm

EVALUATE RESPONSE
Evaluation and consideration during the initiation phase, short-term and long-term follow up

Liffert Vogt (The Netherlands)

12:40pm - 1:00pm

DISCUSSION

ESH MASTERPLAN for hypertension management in CKD

SLOT 1
(2 sessions with the same content)

CHAIRPERSONS

Reinhold Kreutz (Germany)
Liffert Vogt (The Netherlands)

12:00pm - 12:01pm

INTRODUCTION

Reinhold Kreutz (Germany)

12:01pm - 12:14pm

MEASURE BP –DIAGNOSE AND ASSESS PATIENT
BP measurements including ABPM, and the role of measuring uACR

Lene Halvorsen (Norway)

12:14pm - 12:27pm

SELECT THERAPY
BP treatment in patients with CKD including SGLT2i and nsMRA.

Pantelis Sarafidis (Greece)

12:27pm - 12:40pm

EVALUATE RESPONSE
Evaluation and consideration during the initiation phase, short-term and long-term follow up

Liffert Vogt (The Netherlands)

12:40pm - 1:00pm

DISCUSSION

29

April

Tuesday

ESH MASTERPLAN for hypertension management in CKD

SLOT 2
(2 sessions with the same content)

CHAIRPERSONS

Reinhold Kreutz (Germany)

Liffert Vogt (The Netherlands)

5:00pm - 5:01pm

INTRODUCTION

Reinhold Kreutz (Germany)

5:01pm - 5:14pm

MEASURE BP –DIAGNOSE AND ASSESS PATIENT
BP measurements including ABPM, and the role of measuring uACR

Lene Halvorsen (Norway)

5:14pm - 5:27pm

SELECT THERAPY
BP treatment in patients with CKD including SGLT2i and nsMRA.

Pantelis Sarafidis (Greece)

5:27pm - 5:40pm

EVALUATE RESPONSE
Evaluation and consideration during the initiation phase, short-term and long-term follow up

Liffert Vogt (The Netherlands)

5:40pm - 6:00pm

DISCUSSION

ESH MASTERPLAN for hypertension management in CKD

SLOT 2
(2 sessions with the same content)

CHAIRPERSONS

Reinhold Kreutz (Germany)

Liffert Vogt (The Netherlands)

5:00pm - 5:01pm

INTRODUCTION

Reinhold Kreutz (Germany)

5:01pm - 5:14pm

MEASURE BP –DIAGNOSE AND ASSESS PATIENT
BP measurements including ABPM, and the role of measuring uACR

Lene Halvorsen (Norway)

5:14pm - 5:27pm

SELECT THERAPY
BP treatment in patients with CKD including SGLT2i and nsMRA.

Pantelis Sarafidis (Greece)

5:27pm - 5:40pm

EVALUATE RESPONSE
Evaluation and consideration during the initiation phase, short-term and long-term follow up

Liffert Vogt (The Netherlands)

5:40pm - 6:00pm

DISCUSSION

CONTACT

Termedia Publishing House
Kleeberga Str. 2
61-615 Poznań, Poland
tel./faks +48 61 656 22 00
kontakt@termedia.pl
www.termedia.pl